Navigation Links
Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Date:10/1/2013

CORK, Ireland, Oct. 1, 2013 /PRNewswire/ -- Janssen R&D Ireland (Janssen) announced that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease at the upcoming Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place November 1 to 5 in Washington, D.C.

"Simeprevir's clinical profile has been characterized through a robust clinical development program including more than 3,700 patients," said Gaston Picchio, Disease Area Leader Hepatitis, Janssen. "The study results that will be presented at the AASLD Annual Meeting support the potential utility of simeprevir in a number of different hepatitis C patient populations."

Simeprevir was approved in Japan in September 2013 for the treatment of genotype 1 hepatitis C. In the U.S., the New Drug Application (NDA) filed by Janssen for simeprevir administered once daily in combination with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients was granted Priority Review designation by the Food and Drug Administration (FDA) in May. Simeprevir is also being studied in several interferon-free regimens using selected combinations of direct-acting antiviral agents with different mechanisms of action.

The data to be presented at the 2013 AASLD Annual Meeting include:

Poster Presentations: HCV Therapeutics: New Agents, Poster Hall, November 3, 8:00 a.m. - 5:30 p.m. (EST)

  • Simeprevir (TMC435) with peg-interferon alpha-2a/ribavirin for treatment of chronic HCV genotype 1 infection in patients who relapsed after previous interferon-based therapy: Efficacy and safety in patient sub-populations in the PROMIS
    '/>"/>

SOURCE Janssen R&D Ireland
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
2. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
3. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
4. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
5. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
6. U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
7. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
8. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
9. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
10. Bulgaria Launches Development of National Hepatitis Plan
11. Major Breakthrough in Hepatitis C Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... NASHVILLE, Tenn. , July 22, 2014 ... will release second quarter 2014 financial results after the ... call and live Internet webcast will be held on ... to discuss the results. To participate in ... 253-237-1032 (for international callers).  A rebroadcast of the teleconference ...
(Date:7/22/2014)... 22, 2014  Decision Resources Group finds that the market ... will remain relatively stagnant at a value of around ... percutaneous coronary intervention (PCI) volumes are growing faster in ... as the United States and ... by the increase in penetration of PCI procedures relative to ...
(Date:7/22/2014)... Research and Markets  has announced the ... report to their offering. ... diagnose, monitor, and assess medical conditions, diseases, or infections ... for earlier and more targeted treatment. These tests are ... results. This kind of diagnostics provides early detection of ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3
... CALGARY, Alberta, July 13, 2011 Fero Industries, ... report that Merck S.A. de C.V. has successfully ... points-of-sale to over 2,500 outlets and pharmacy chains. ... well-known retailers including WalMart Supercenters, Superama, Farmacias del ...
... Schein, Inc. (NASDAQ: HSIC ), the largest provider ... the Henry Schein Cares Foundation, Inc., announced today a contribution ... help provide health care to those who have been affected ... earthquake in New Zealand, and tornadoes in the United States. ...
Cached Medicine Technology:Fero Industries Expands Sucanon® Distribution in Mexico 2Fero Industries Expands Sucanon® Distribution in Mexico 3Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 2Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 3
(Date:7/22/2014)... (WASHINGTON, July 22, 2014) The American Society ... of the University of California Los Angeles with ... research in iron homeostasis, including the discovery of the ... iron metabolism. This award, named after the Nobel Prize ... recognizes pioneering research achievements in hematology that have represented ...
(Date:7/22/2014)... you eat pretty much everything you put on your ... study shows that the average adult eats 92% of whatever ... "If you put it on your plate, it,s going ... forthcoming book, Slim by Design, Professor of Marketing and Director ... co-author Katherine Abowd Johnson analyzed 1179 diners and concluded that ...
(Date:7/22/2014)... American Society of Hematology (ASH) will present the Society,s ... Lifetime Achievement in Hematology, to Kanti R. Rai, MD, ... of Medicine for his 50-year career combining landmark clinical ... exceptional patient care. , The Wallace H. Coulter ... an individual who has been a vital contributor to ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
(Date:7/22/2014)... 6th Latin American Conference on Lung Cancer (LALCA 2014) ... Lima, Peru. , Lung Cancer is still the leading ... worldwide. Building on the success of the previous conferences ... speakers will discuss the science and advances in the ... worldwide and Latin America in particular. , With tobacco ...
Breaking Medicine News(10 mins):Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
... By Jenifer Goodwin HealthDay Reporter , MONDAY, Aug. ... Go for a walk after dinner. Play tag with your kids ... of exercise -- about 150 minutes, or 2.5 hours, of moderate ... by about 14 percent. Those who did more -- about ...
... -- Suicide is the 11th leading cause of death in ... taking their own lives. Sadly, each year tens of thousands ... family and friends, some warning signs exist. Often a simple ... a person toward help and treatment. A new ...
... While deformities of the lesser toes (all toes other than ... surgical and nonsurgical treatments for these conditions that are usually ... of the American Academy of Orthopaedic Surgeons (JAAOS) shows ... be symptoms of other conditions, early assessment and treatment by ...
... elderly people in the US, registered with Medicare, do not ... according to Dr. Larissa Nekhlyudov and colleagues from Harvard Medical ... and the National Cancer Institute, shows that cost-related medication non-adherence ... not filling in a prescription because it is too expensive ...
... CORAL GABLES, FL (August 1, 2011) Researchers from the ... Germany have developed a mathematical model to understand and predict ... metastasis, in hopes of creating highly personalized treatment strategies for ... new online journal Scientific Reports . When a ...
... 2011 Annual Meeting & OTO EXPO of the American ... (AAO-HNSF), the largest meeting of ear, nose, and throat ... in San Francisco, CA. Featuring more than 386 ... course hours for attendees, the annual meeting is a ...
Cached Medicine News:Health News:Even a Little Exercise Helps the Heart, Study Finds 2Health News:Even a Little Exercise Helps the Heart, Study Finds 3Health News:Mayo Clinic: Primary physicians may hold key to suicide prevention 2Health News:Don't suffer in silence with toe pain 2Health News:Barrier to effective treatment for seniors -- the cost of medicine 2Health News:Using math to fight cancer 2Health News:World's largest meeting of ear, nose and throat doctors 2
Y shape rotator tip. Shaft angled 7 mm from tip to bend. Round knurled handle with polished finish. Most popular size or model....
1.0 mm long 90 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
Delicate pick with 90 degree hook tip. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 110 degrees. Most popular size or model....
Medicine Products: